Thinking of Buying Pfizer Stock? Here's What You Need to Know

Big pharma company Pfizer (NYSE: PFE) has been around for more than 170 years. But the coronavirus pandemic marked its opportunity to take center stage. Pfizer last year partnered with German biotech BioNTech and won the first Emergency Use Authorization for a coronavirus vaccine. Now, the duo are market leaders. They've fully vaccinated more than 99 million Americans.

At the same time, Pfizer stock hasn't exactly soared. It was little changed last year. And this year, the shares have climbed about 19%. So, is this the right time to buy Pfizer stock? Let's take a look at what you need to know before taking the plunge.

Image source: Getty Images.

Continue reading


Source Fool.com